Fariborz Kamal
2023
In 2023, Fariborz Kamal earned a total compensation of $4.5M as Chief Operating Officer & President at 4D Molecular Therapeutics, a 90% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $296,812 |
|---|---|
| Option Awards | $3,758,059 |
| Salary | $489,389 |
| Total | $4,544,260 |
Kamal received $3.8M in option awards, accounting for 83% of the total pay in 2023.
Kamal also received $296.8K in non-equity incentive plan and $489.4K in salary.
Rankings
In 2023, Fariborz Kamal's compensation ranked 149th out of 2,907 executives tracked by ExecPay. In other words, Kamal earned more than 94.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 149 out of 2,907 | 95th |
Division Manufacturing | 81 out of 1,599 | 95th |
Major group Chemicals And Allied Products | 49 out of 901 | 95th |
Industry group Drugs | 48 out of 864 | 94th |
Industry Biological Products, Except Diagnostic Substances | 16 out of 211 | 92nd |
Source: SEC filing on April 10, 2024.
Kamal's colleagues
We found two more compensation records of executives who worked with Fariborz Kamal at 4D Molecular Therapeutics in 2023.